Metametrix Clinical Laboratory
FAQ | Ordering Info | Site Map | Contact Us


 
References ADMA
 

Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease
Boger RH, Bode-Boger SM, Thiele W, Junker W, Alexander K, Frolich JC [see comments]. Circulation. 1997;95(8):2068-2074.

Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively
metabolized by dimethylarginine dimethylaminohydrolase.

Achan V, Broadhead M, Malaki M, et al. Arterioscler Thromb Vasc Biol. Aug 1 2003;23(8):1455-1459.

Plasma asymmetric dimethylarginine and hyperemic myocardial blood flow in young subjects with borderline hypertension or familial hypercholesterolemia.
Paiva H, Laakso J, Laine H, Laaksonen R, Knuuti J, Raitakari OT. J Am Coll Cardiol. Oct 2 2002;40(7):1241-1247.

Oral L-arginine improves endothelial function in healthy individuals older than 70 years.
Bode-Boger SM, Muke J, Surdacki A, Brabant G, Boger RH, Frolich JC. Vasc Med. May 2003;8(2):77-81.

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.
Nijveldt RJ, Teerlink T, Van Der Hoven B, et al. Clin Nutr. Feb 2003;22(1):23-30.

Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease.
Eid HM, Eritsland J, Larsen J, Arnesen H, Seljeflot I. Effects of pravastatin. Atherosclerosis. Feb 2003;166(2):279-284.

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.
Stuhlinger MC, Abbasi F, Chu JW, et al. Jama. Mar 20 2002;287(11):1420-1426.

Dietary composition as a determinant of plasma asymmetric dimethylarginine in subjects with mild hypercholesterolemia.
Paiva H, Lehtimaki T, Laakso J, et al. Metabolism. Aug 2004;53(8):1072-1075.

Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma
concentrations of asymmetric dimethylarginine

Lundman P, Eriksson MJ, Stuhlinger M, Cooke JP, Hamsten A, Tornvall P. J Am Coll Cardiol. Jul 2001;38(1):111-116.

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in hyperthyroid patients.
Hermenegildo C, Medina P, Peiro M, et al. J Clin Endocrinol Metab. Dec 2002;87(12):5636-5640.

Does ADMA cause endothelial dysfunction?
Cooke JP. Arterioscler Thromb Vasc Biol. 2000;20(9):2032-2037.